Turn this list into pipeline.
Generic Pharma Companies in London: 46 Active Firms (2026)
Generic pharma companies in London develop, license and supply off-patent medicines that match reference products under UK regulation.
Buying centres sit mainly in regulatory affairs, procurement, hospital pharmacy and wholesale supply, rather than in consumer-facing brand teams. London operators typically sell into business and public healthcare channels: wholesalers, pharmacy groups, hospital procurement teams and import or licensing partners. Engagements tend to be product-by-product, with quality assurance, pharmacovigilance, batch release, continuity of supply and pricing discipline carrying as much weight as sales reach. The commercial shape is lean and specialist, with regulatory, quality, supply chain and tendering roles often sitting close to senior management.
Read more
London has 46 actively trading generic pharma firms in this list, making it a compact regional cohort rather than a broad manufacturing base. Reported employment is 196 people across the London group, and 31 of 31 firms with headcount reporting disclose at least one employee. Commercial scale is uneven: 9 firms report turnover above £5M, while 7 were incorporated since 2022. That mix points to a market with a small number of established suppliers and a visible intake of newer licensing, import and supply vehicles.
Human medicines sit under MHRA oversight, with generic applications assessed against the legal tests in the Human Medicines Regulations rather than against a looser similarity claim. GOV.UK guidance frames UK-wide marketing authorisations as the route for licensing across the country, and generic products must match the reference medicinal product on active substance and pharmaceutical form while demonstrating bioequivalence. Medicines UK represents the off-patent generic, biosimilar and value-added medicines sector, so policy debate tends to centre on access, substitution, shortages and public healthcare purchasing economics.
London’s generic pharma base appears likely to remain more commercial and regulatory than factory-led. New entrants tend to assemble authorisations, import routes and specialist quality systems before they build visible headcount, while established suppliers are more exposed to tender pressure and availability risk than to consumer demand cycles. Scarcity of larger scale-ups may keep consolidation on the table, especially where portfolios overlap or where compliance costs rise. The sector has been useful to public healthcare because it supplies interchangeable medicines, but margins can stay thin when procurement bodies press for lower prices.
46
Active firms
2026
9
Above £5M
annual revenue
7
Since 2022
incorporated firms
Key facts
About 19% of the trading cohort reports turnover above £5M (9 of 46 firms) — the rest sits below that revenue band.
15% of the cohort was incorporated since 2022 (7 firms), so a sizeable share is in its first few filing cycles.
From 1 January 2025, the MHRA licenses human medicines across the whole UK through UK-wide marketing authorisations.
Generic applications sit under Regulation 51B of the Human Medicines Regulations 2012, with products required to have the same active substance, the same pharmaceutical form and bioequivalence to the reference medicinal product.
Medicines UK puts annual healthcare-budget savings from generic, biosimilar and value-added medicines at more than £20 billion.
Generic, biosimilar and value-added medicines fulfil more than four out of five patient prescriptions in public healthcare.
OECD search results describe the UK as one of the higher-penetration generic-medicine markets: in 2021, generics accounted for more than three-quarters of pharmaceutical volume sold in the United Kingdom.
Top London Generic Pharma companies
Ria Generics Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsManufactures and wholesales generic pharmaceutical products. Acts as a marketing authorisation holder, importer and batch‑release site, and supplies licensed and unlicensed medicinal products to…
Serves pharmaceutical distributors and approved wholesale dealers in the UK and Europe, plus non-EU/UK brands requiring licensed or unlicensed generic medicines under their own label.
Financial Health
StrongStrong · Growing · 0% CAGR over 5y
Location
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops, manufactures, markets and distributes generic pharmaceutical medicines. Supplies a range of prescription drugs including analgesics, cardiovascular and antibiotic treatments such as…
Serves NHS contractors, pharmaceutical suppliers and wholesale/distribution buyers in the UK market for generic medicines.
Financial Health
WeakWeak
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, in-licenses, manufactures and markets pharmaceutical products, focusing on generic and specialty medicines. Operates research and development and manufacturing for products including…
Serves healthcare markets with generic and specialty pharmaceutical products, selling primarily to healthcare providers, pharmacies and pharmaceutical distribution channels, while also partnering…
Financial Health
StableStable · 0% CAGR over 2y
Location
CELIX PHARMA LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and commercialises generic and branded generic medicines and hospital specialty pharmaceuticals. Works with R&D and manufacturing partners to take products from development and regulatory…
Serves UK and European healthcare markets, selling to retail pharmacy and hospital channels, primary and secondary care providers, payers, and pharmaceutical partners.
Financial Health
HealthyHealthy
Location
LONDON UNITED EXPORTS LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, manufactures, exports and markets off‑patent prescription medicines and consumer healthcare products. Supplies a portfolio of pharmaceutical products across multiple therapeutic categories…
Serves healthcare providers, practitioners, pharmaceutical distributors and consumer healthcare markets in major and developing markets across more than 20 countries.
Financial Health
StableStable · -90% CAGR over 2y
Location
BRANCASTER LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops and supplies pharmaceutical medicines for clinical use, including midodrine hydrochloride (Bramox), benzylpenicillin benzathine, thiamine hydrochloride injections, and varenicline…
Serves patients with rarer conditions and the healthcare professionals involved in their treatment, particularly where listed prescription medicines are relevant.
Financial Health
DistressedDistressed · -13% CAGR over 3y
Location
BROWN & BURK UK LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsManufactures, markets and distributes generic pharmaceutical medicines. Supplies EU GMP‑compliant products including antibiotics and other prescription drugs, and manages pharmaceutical supply chains…
Serves B2B healthcare and pharmaceutical buyers, including distributors and supply-chain partners sourcing generic medicinal products across the UK and Europe.
Financial Health
HealthyHealthy · -51% CAGR over 5y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsMarkets and supplies generic pharmaceutical medicines to wholesale distributors, pharmacies, and healthcare providers. Licenses and markets medicines from third parties and develops generic drugs…
Serves UK pharmaceutical wholesalers, retail pharmacy channels and secondary care healthcare providers, with additional relationships with third-party product licensing partners.
Financial Health
WeakWeak · Hiring · 6% CAGR over 2y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsResearches, develops and licenses generic pharmaceutical products for human and veterinary use, focusing on complex and niche molecules. Works with contract manufacturers to produce medicines and…
Serves B2B pharmaceutical and healthcare customers, including payors, healthcare providers, wholesalers, prescribers and pharmacies, plus companies seeking licensing, acquisitions, co-development or…
Financial Health
StableStable · Hiring · 19% CAGR over 4y
Location
FLAMINGO PHARMA (UK) LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsWholesales prescription and over‑the‑counter pharmaceutical products. Acquires, develops and markets generic medicines, supplying tablets, capsules and other treatments through licensing,…
Serves B2B customers in the UK pharmaceuticals market, including healthcare providers and partners seeking generic medicines, own-label supply arrangements and product availability information.
Financial Health
HealthyHealthy · -88% CAGR over 2y
Location
Chemilines Group
Imports and distributes branded and generic pharmaceutical medicines. Manufactures wound care products and medical devices through group companies, and supplies healthcare products to pharmacies and…
Serves B2B healthcare and pharmaceutical buyers in the UK, including pharmacy buyers, hospital procurement teams, and purchasers of medicines, woundcare products and medical devices.
Location
TARGET HEALTHCARE INTERNATIONAL LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and manufactures generic, branded and unlicensed medicines to pharmacies, hospitals, dispensing doctors and wholesalers. Provides custom “specials” medicines, parallel imports, medical…
Serves pharmacies, hospitals, dispensing doctors, pharmaceutical wholesalers and buying groups in the UK and internationally, including healthcare providers and distributors needing licensed,…
Financial Health
StableStable · 1% CAGR over 4y
Location
Trajectory
2y · 2022–NowFinancial sub-scores
Computed from 2 filingsProvides pharmaceutical distribution and regulatory compliance services for drug product owners, including supply chain planning, warehousing, quality release, order management and transport, as well…
Targets B2B pharmaceutical product owners, marketing authorisation holders, and life sciences companies managing medicines portfolios, especially firms commercialising or transferring products across…
Financial Health
StableStable · 9% CAGR over 1y
Location
Trajectory
2y · 2022–NowProvides pharmaceutical distribution and regulatory compliance services for drug product owners. Activities include supply chain planning, warehousing, order management, transportation to customers,…
Serves B2B pharmaceutical product owners, marketing authorisation holders and biotech/pharma companies needing outsourced distribution and regulatory compliance support for medicines across Europe…
Financial Health
Insufficient historyInsufficient history
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and supplies prescription pharmaceutical products, including melatonin, desmopressin, N‑acetylcysteine and electrolyte formulations. Manages a portfolio of branded medicines for healthcare…
Serves NHS organisations, healthcare professionals, prescribers, pharmacists and patients needing prescription pharmaceutical products, with customer relationships in the UK and selected…
Financial Health
StableStable · 0% CAGR over 2y
Location
RKONNECT LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDistributes prescription and over-the-counter medicines and medical devices as a pharmaceutical wholesaler. Provides pharmaceutical logistics, GDP-compliant storage and warehousing, global sourcing…
Serves community pharmacies, hospitals, healthcare sites, pharmaceutical partners and clinical research organisations in the UK and worldwide needing regulated medicine, medical device and trial…
Financial Health
StableStable · -16% CAGR over 4y
Location
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops and supplies pharmaceutical products and diagnostic tests, focusing on treatments in rheumatology, urology, haematology, and oncology. Works on improving established medicines and developing…
Targets healthcare professionals and healthcare organisations in rheumatology, urology, haematology and oncology, particularly those managing patients with specialist therapeutic needs.
Financial Health
StrongStrong · Hiring · 90% CAGR over 4y
Location
PHARMA - EXPORT LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsSupplies and exports pharmaceutical products and medical devices, including generic medicines and vitamin products. Distributes a range of branded and newly developed drugs to international…
Serves international pharmaceutical distributors, government health ministries, hospitals and pharmacies seeking UK-supplied medicines and medical devices.
Financial Health
StrongStrong · Growing, Hiring · 5% CAGR over 4y
Location
NECESSITY SUPPLIES LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsImports, exports and wholesales pharmaceutical products, supplying generic and branded medicines and healthcare items such as tablets, syringes, creams, inhalers and test strips to pharmacies,…
Serves pharmacies, pharmaceutical wholesalers and distributors, hospitals and care homes in the UK, Europe and globally, targeting buyers in healthcare and care-sector medicine supply chains.
Financial Health
StableStable · Hiring · 7% CAGR over 4y
Location
BRUNSWICK TRADING LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides wholesale procurement and distribution of pharmaceutical and healthcare products, including UK generic and branded medicines, medical devices and dressings. Also conducts parallel import and…
Serves licensed pharmaceutical wholesalers, distributors and healthcare product businesses sourcing generics, branded medicines, medical devices and dressings across Europe, the Middle East and…
Financial Health
DistressedDistressed · -11% CAGR over 2y
Location
Laxmico Limited
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsDistributes pharmaceutical products to independent pharmacies, including generic medicines, parallel imports, OTC products, dressings and nutritional feeds. Provides ordering via web portal and…
Serves independent community pharmacies across the UK, supplying pharmacy owners and buyers with pharmaceutical, healthcare and OTC product ranges through B2B ordering channels.
Financial Health
StableStable · 3% CAGR over 2y
Location
MEDEX PHARMA LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsImports, exports and wholesales branded and generic medicines, vaccines, over‑the‑counter medicines, and health and beauty products. Procures pharmaceutical stock from manufacturers and distributors,…
Serves pharmacies, pharmaceutical distributors, importers/exporters and healthcare businesses needing wholesale supply of medicines, vaccines, OTC and health products, including cold-chain lines, in…
Financial Health
HealthyHealthy · Hiring · 9% CAGR over 4y
Location
LV GLOBAL LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsWholesales pharmaceutical and healthcare products, sourcing medicines from approved manufacturers and distributing them globally. Procures, imports and exports branded and generic drugs, including…
Serves B2B pharmaceutical and healthcare organisations worldwide, including enterprises of varying sizes needing branded, generic, OTC, hard-to-find, unlicensed or shortage medicines.
Financial Health
HealthyHealthy · 0% CAGR over 4y
Location
K Waterhouse Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDistributes pharmaceutical products to pharmacies and wholesalers, including generic medicines, over‑the‑counter drugs, dietary supplements, toiletries and pharmacy sundries. Holds MHRA licences to…
Serves B2B customers in the pharmacy supply chain, including retail pharmacies, pharmaceutical wholesalers and logistics partners needing medicines, generics, counter medicines, supplements,…
Financial Health
WeakWeak · 0% CAGR over 2y
Location
DALE HEATH LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides wholesale supply of branded pharmaceuticals, generic medicines and over‑the‑counter healthcare products to pharmacies, clinics and medical distributors, operating under a UK wholesale dealer…
Sells to B2B buyers in the UK pharmaceutical supply chain, including pharmacies, healthcare wholesalers and retailers sourcing branded medicines, generics and over-the-counter products.
Financial Health
StrongStrong · Growing, Hiring · 15% CAGR over 4y
Location
KORA HEALTHCARE UK LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and commercialises pharmaceutical and healthcare products across multiple therapeutic areas, including supportive care and genitourinary medicine. Supplies prescription medicines and…
Serves healthcare providers, public-sector health buyers and patients needing supportive care or genito-urinary treatments, including for chronic conditions and sexual or reproductive health.
Financial Health
HealthyHealthy · 0% CAGR over 4y
Location
SQR PHARMA CONSULTING LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsWholesales and exports pharmaceutical products, including generic and OTC medicines, to international markets. Provides regulatory, commercial and operational support to manufacturers, including…
Serves pharmaceutical manufacturers and companies expanding into foreign markets, plus international organisations and foreign government buyers needing supplies of generic, OTC and specialist…
Financial Health
HealthyHealthy · Profitable, Hiring · 41% CAGR over 4y
Location
Mayors Healthcare Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsSupplies Clinipod sterile saline wound irrigation pods and other generic over‑the‑counter healthcare products. Operates as a licensed pharmaceutical wholesaler distributing CE‑marked medical devices…
Sells B2B to UK pharmaceutical wholesalers, retail pharmacy supply chains and NHS Trust procurement teams, including buyers managing budgets for medical consumables such as Clinipod.
Financial Health
StableStable · Hiring · 22% CAGR over 2y
Location
Natco Pharma UK Limited
Trajectory
3y · 2024–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
StableStable
Location
Unlock all 46 leads
Showing 29 of 46 — +17 more with verified decision-maker contacts, live data, and CRM sync.
How London Generic Pharma companies work and how to sell to them
What they do
Revenue in generic pharma comes from authorised off-patent medicines supplied into regulated healthcare channels. London firms in this segment tend to earn through product margins, wholesale agreements, tenders, import arrangements and licensing support, rather than consumer advertising or subscription pricing. Commercial engagement is usually organised around individual molecules, dosage forms and pack presentations, with batch availability and documentation shaping the economics. Unit contribution depends on purchase price, release timing, stock cover, rebates and tender terms. Services revenue may appear around regulatory submissions, market access or distribution support, but the centre of gravity is still regulated product supply.
Who they sell to
Most customers are professional healthcare buyers: hospital pharmacy teams, pharmacy groups, wholesalers, procurement frameworks and overseas principals looking for UK routes to market. Decision-making usually involves procurement, regulatory affairs, quality, medical information and finance, with senior management pulled in when supply risk or tender exposure is material. Contract values vary by molecule, volume and exclusivity, so buyers tend to assess availability and compliance evidence alongside price. Sales cycles are usually measured in months rather than weeks, especially where a formal tender, wholesaler listing, product due diligence or marketing authorisation work is involved.
What they buy
Most generic pharma firms tend to spend on systems and services that reduce compliance burden or protect margin. Common software categories include regulatory information management, electronic quality management, pharmacovigilance case handling, batch documentation, secure document management, ERP, inventory planning, demand forecasting, pricing analytics, CRM and tender tracking. Service spend often sits with regulatory writing, MHRA submission support, quality audits, legal advice, tax and accounting, pharmacovigilance outsourcing, logistics, warehousing and specialist recruitment. Smaller commercial teams may still run parts of the operation through spreadsheets and email, which makes workflow control, audit trails and exception management a credible sales angle.
Why and how to sell to them
Generic pharma buyers tend to evaluate vendors when compliance work starts to outgrow lean teams, when a new product portfolio is added, or when tender pressure exposes gaps in forecasting and stock control. Other triggers include senior hires in regulatory affairs or quality, new import or distribution arrangements, audit findings, supply interruptions and a move from opportunistic trading into repeat healthcare supply. Outbound messages usually work better when they name the operational risk being reduced: delayed variation submissions, missed tender deadlines, weak batch traceability, avoidable stock-outs or manual pharmacovigilance follow-up. Price sensitivity is common, so evidence of lower rework, faster documentation or better margin control matters.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in London
Related directories
Frequently asked questions
How many Generic Pharma companies are there in the London?↓
What counts as a Generic Pharma company in this list?↓
Which are the largest Generic Pharma companies in the London?↓
What do Generic Pharma companies in the London actually do?↓
How does London Generic Pharma compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical Generic Pharma companies in the London?↓
Are these mostly new or established Generic Pharma companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 46 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.